Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.

about

Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma.Chemotherapy in Pancreatic Cancer: A Systematic Review

P2860

Q38721161-C1DA03C5-AA69-40CE-A6D3-6FABF0CF26D7 Q57824846-7A1E0442-481A-4305-A7A5-B0A1DE42CF44

P2860

Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.

Item

http://www.wikidata.org/entity/Q40631094

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combination gemcitabine/cispla ...... a Phase II prospective trial.

@en

type

Item

label

Combination gemcitabine/cispla ...... a Phase II prospective trial.

@en

prefLabel

Combination gemcitabine/cispla ...... a Phase II prospective trial.

@en

P1476

Combination gemcitabine/cispla ...... f a Phase II prospective trial

@en

P2093

Bassel El-Rayes

http://www.w3.org/2001/XMLSchema#string

Cecilia G Ethun

http://www.w3.org/2001/XMLSchema#string

Charles A Staley

http://www.w3.org/2001/XMLSchema#string

David A Kooby

http://www.w3.org/2001/XMLSchema#string

Edith Brutcher

http://www.w3.org/2001/XMLSchema#string

Juan M Sarmiento

http://www.w3.org/2001/XMLSchema#string

Lauren M Postlewait

http://www.w3.org/2001/XMLSchema#string

Shishir K Maithel

http://www.w3.org/2001/XMLSchema#string

Zhengjia Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

P304

336-341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24317

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Volkan Adsay

P577

2016-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27501338

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.

about

P2860

P2860

Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921